Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: J Geriatr Oncol. 2014 Sep 18;5(4):343–351. doi: 10.1016/j.jgo.2014.08.004

Table 1.

Patient Characteristics

Characteristic N %
Total 5824
Age (in years)
67-69 1155 19.8
70-74 2193 37.7
75-79 1521 26.1
80-84 738 12.7
85-94 217 3.7
Race
White 4830 82.9
Black 533 9.2
Other 461 7.9
Income
<$33K 1441 24.7
$33K - <$40K 942 16.2
$40K - <$50K 1107 19.0
$50K - <$63K 958 16.5
≥$63K 1376 23.6
Year of Diagnosis
2007 2635 45.2
2008 2512 43.1
2009 677 11.6
Radiation therapy
No 1200 20.6
Yes 4624 79.4
ADT
None 2534 43.5
Hormone (1-3 units) 599 10.3
Hormone (4-8 units) 1881 32.3
Hormone (≥9 units) 810 13.9
Tumor Grade
Well-differentiated 29 0.5
Moderately-differentiated 2256 38.7
Poorly-differentiated 3517 60.4
Undifferentiated 22 0.4
Clinical T Stage
I 3457 59.4
II 2367 40.6
Elixhauser Score
0 2532 43.5
1-2 2376 40.8
≥3 916 15.7
Anxiety
No 5712 98.1
Yes 112 1.9
Dementia
No 5764 99.0
Yes 60 1.0
Parkinson's
No 5749 98.7
Yes 75 1.3
Osteoporosis
No 5690 97.7
Yes 134 2.3
Medications that cause osteoporosis*
No 5725 98.3
Yes 99 1.7
Medications that cause falls (CNS)
No 5448 93.5
Yes 376 6.5
Medications that cause falls (Antihypertensive)
No 3855 66.2
Yes 1969 33.8
Disability score
Q1 1456 25.0
Q2-Q4 4368 75.0
*

Medications that cause osteoporosis include: calcineurin inhibitors and glucocorticoids.

Central nervous system-active medications include: tricyclic agents, antipsychotics, and atypical antipsychotics).

Antihypertensive medications include: peripheral alpha-1 receptor blockers, central alpha-2 receptor agonists, cardiac and non-cardiac selective medications and alpha-beta blockers.